Tumilasci O R, Houssay A B, Sosto N E, Paz C V, Varela V
J Endocrinol Invest. 1986 Feb;9(1):51-5. doi: 10.1007/BF03348063.
The effect of changes in thyroid function upon vasoactive intestinal peptide (VIP) induced secretion of saliva were studied in male Wistar rats. Hyperthyroidism was induced by the sc administration every 12 h of 10 micrograms/100 g bw of I-triiodothyronine; hypothyroidism was induced by surgical thyroidectomy 2 weeks before the experiments. Preganglionar parasympathetic denervation was induced by sectioning the chorda tympani on the left side. The dose-response curves to increasing doses of VIP showed in the hypothyroid animals increased salivary secretion, while in the hyperthyroid ones the dose-response to the drug was reduced. This effect was seen on both sides, the denervated and the control ones. In the denervated glands there was a marked hypersensitivity to the administration of VIP producing greater responses with the same doses, in the 3 groups of animals. The negative modulation by thyroid hormones of the salivary response to VIP administration is compared with the positive modulation they induce in the salivary response to beta-adrenergic and cholinergic drugs.
在雄性Wistar大鼠中研究了甲状腺功能变化对血管活性肠肽(VIP)诱导唾液分泌的影响。通过每12小时皮下注射10微克/100克体重的L-三碘甲状腺原氨酸诱导甲状腺功能亢进;甲状腺功能减退通过在实验前2周进行甲状腺切除术诱导。通过切断左侧鼓索神经诱导节前副交感神经去神经支配。对不同剂量VIP的剂量-反应曲线显示,甲状腺功能减退动物的唾液分泌增加,而甲状腺功能亢进动物对药物的剂量-反应降低。在去神经支配侧和对照侧均观察到这种效应。在去神经支配的腺体中,对VIP给药有明显的超敏反应,在三组动物中相同剂量下产生更大的反应。将甲状腺激素对VIP给药的唾液反应的负调节与它们对β-肾上腺素能和胆碱能药物的唾液反应诱导的正调节进行了比较。